Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels C Riedemann

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Expert Opinion on Biological Therapy|March 29, 2003
Anti-inflammatory strategies for the treatment of sepsisNiels C Riedemann, Peter A Ward
Nature Medicine|October 3, 2002
Oxidized lipid protects against sepsisNiels C Riedemann, Peter A Ward
The American Journal of Pathology|January 28, 2003
Complement in ischemia reperfusion injuryNiels C Riedemann, Peter A Ward
Nature Medicine|May 2, 2003
Novel strategies for the treatment of sepsisNiels C Riedemann, Ren-Feng Guo, Peter A Ward
Journal of Leukocyte Biology|September 10, 2003
A key role of C5a/C5aR activation for the development of sepsisNiels C Riedemann, Ren-Feng Guo, Peter A Ward
Shock (Augusta, Ga.)|December 17, 2003
Role of C5a-C5aR interaction in sepsisRen-Feng Guo, Niels C Riedemann, Peter A Ward
The Journal of Clinical Investigation|August 20, 2003
The enigma of sepsisNiels C Riedemann, Ren-Feng Guo, Peter A Ward
Critical Care Research and Practice|April 7, 2012
Manipulation of the complement system for benefit in sepsisPeter A Ward, Ren-Feng Guo, Niels C Riedemann
Clinical Microbiology Reviews|October 5, 2012
New approaches to sepsis: molecular diagnostics and biomarkersKonrad Reinhart, Michael Bauer, Niels C Riedemann, et al.
International Journal of Molecular Sciences|October 16, 2025
A Targeted Blockade of Terminal C5a Is Critical to Management of Sepsis and Acute Respiratory Distress Syndrome: The Mechanism of Action of VilobelimabMatthew W McCarthy, Camilla Chong, Niels C Riedemann, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Expert Opinion on Biological Therapy|March 29, 2003
Anti-inflammatory strategies for the treatment of sepsisNiels C Riedemann, Peter A Ward
Nature Medicine|October 3, 2002
Oxidized lipid protects against sepsisNiels C Riedemann, Peter A Ward
The American Journal of Pathology|January 28, 2003
Complement in ischemia reperfusion injuryNiels C Riedemann, Peter A Ward
Nature Medicine|May 2, 2003
Novel strategies for the treatment of sepsisNiels C Riedemann, Ren-Feng Guo, Peter A Ward
Journal of Leukocyte Biology|September 10, 2003
A key role of C5a/C5aR activation for the development of sepsisNiels C Riedemann, Ren-Feng Guo, Peter A Ward
Shock (Augusta, Ga.)|December 17, 2003
Role of C5a-C5aR interaction in sepsisRen-Feng Guo, Niels C Riedemann, Peter A Ward
The Journal of Clinical Investigation|August 20, 2003
The enigma of sepsisNiels C Riedemann, Ren-Feng Guo, Peter A Ward
Critical Care Research and Practice|April 7, 2012
Manipulation of the complement system for benefit in sepsisPeter A Ward, Ren-Feng Guo, Niels C Riedemann
Clinical Microbiology Reviews|October 5, 2012
New approaches to sepsis: molecular diagnostics and biomarkersKonrad Reinhart, Michael Bauer, Niels C Riedemann, et al.
International Journal of Molecular Sciences|October 16, 2025
A Targeted Blockade of Terminal C5a Is Critical to Management of Sepsis and Acute Respiratory Distress Syndrome: The Mechanism of Action of VilobelimabMatthew W McCarthy, Camilla Chong, Niels C Riedemann, et al.
Pageof 6